nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—ADRB2—coronary artery disease	0.231	1	CbGaD
Salmeterol—ADRB2—Penbutolol—coronary artery disease	0.0469	0.0858	CbGbCtD
Salmeterol—ADRB2—Timolol—coronary artery disease	0.0331	0.0604	CbGbCtD
Salmeterol—CYP2C8—Fenofibrate—coronary artery disease	0.0266	0.0487	CbGbCtD
Salmeterol—CYP3A7—Eplerenone—coronary artery disease	0.0238	0.0435	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0238	0.0435	CbGbCtD
Salmeterol—CYP2C8—Gemfibrozil—coronary artery disease	0.0213	0.0389	CbGbCtD
Salmeterol—CYP3A5—Clopidogrel—coronary artery disease	0.0192	0.0351	CbGbCtD
Salmeterol—CYP2C8—Clopidogrel—coronary artery disease	0.0185	0.0337	CbGbCtD
Salmeterol—CYP3A5—Eplerenone—coronary artery disease	0.0178	0.0326	CbGbCtD
Salmeterol—CYP2C8—Pitavastatin—coronary artery disease	0.0161	0.0295	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0153	0.028	CbGbCtD
Salmeterol—CYP3A7—Simvastatin—coronary artery disease	0.0153	0.028	CbGbCtD
Salmeterol—CYP3A7—Lovastatin—coronary artery disease	0.015	0.0274	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.015	0.0274	CbGbCtD
Salmeterol—CYP3A7—Atorvastatin—coronary artery disease	0.0137	0.025	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0137	0.025	CbGbCtD
Salmeterol—CYP3A5—Rosuvastatin—coronary artery disease	0.0124	0.0226	CbGbCtD
Salmeterol—CYP3A4—Ticagrelor—coronary artery disease	0.0121	0.0221	CbGbCtD
Salmeterol—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0116	0.0212	CbGbCtD
Salmeterol—CYP3A5—Simvastatin—coronary artery disease	0.0115	0.021	CbGbCtD
Salmeterol—CYP3A5—Pravastatin—coronary artery disease	0.0113	0.0206	CbGbCtD
Salmeterol—CYP3A5—Lovastatin—coronary artery disease	0.0113	0.0206	CbGbCtD
Salmeterol—CYP2C8—Simvastatin—coronary artery disease	0.0111	0.0202	CbGbCtD
Salmeterol—CYP2C8—Pravastatin—coronary artery disease	0.0108	0.0198	CbGbCtD
Salmeterol—CYP2C8—Lovastatin—coronary artery disease	0.0108	0.0198	CbGbCtD
Salmeterol—CYP3A4—Fenofibrate—coronary artery disease	0.0108	0.0197	CbGbCtD
Salmeterol—CYP3A5—Atorvastatin—coronary artery disease	0.0103	0.0187	CbGbCtD
Salmeterol—CYP2C8—Atorvastatin—coronary artery disease	0.00986	0.018	CbGbCtD
Salmeterol—CYP3A5—Losartan—coronary artery disease	0.00938	0.0171	CbGbCtD
Salmeterol—CYP2C8—Losartan—coronary artery disease	0.00902	0.0165	CbGbCtD
Salmeterol—CYP3A4—Gemfibrozil—coronary artery disease	0.00864	0.0158	CbGbCtD
Salmeterol—CYP3A4—Clopidogrel—coronary artery disease	0.00749	0.0137	CbGbCtD
Salmeterol—CYP3A4—Eplerenone—coronary artery disease	0.00696	0.0127	CbGbCtD
Salmeterol—CYP3A4—Enalapril—coronary artery disease	0.0062	0.0113	CbGbCtD
Salmeterol—CYP3A4—Rosuvastatin—coronary artery disease	0.00482	0.00882	CbGbCtD
Salmeterol—CYP3A4—Ezetimibe—coronary artery disease	0.00482	0.00882	CbGbCtD
Salmeterol—CYP3A4—Simvastatin—coronary artery disease	0.00449	0.0082	CbGbCtD
Salmeterol—CYP3A4—Pravastatin—coronary artery disease	0.00439	0.00802	CbGbCtD
Salmeterol—CYP3A4—Lovastatin—coronary artery disease	0.00439	0.00802	CbGbCtD
Salmeterol—CYP3A4—Atorvastatin—coronary artery disease	0.004	0.00731	CbGbCtD
Salmeterol—CYP3A4—Losartan—coronary artery disease	0.00366	0.00668	CbGbCtD
Salmeterol—Arbutamine—ADRB1—coronary artery disease	0.000489	0.183	CrCbGaD
Salmeterol—Salbutamol—ADRB1—coronary artery disease	0.000475	0.177	CrCbGaD
Salmeterol—Arbutamine—ADRB2—coronary artery disease	0.000411	0.154	CrCbGaD
Salmeterol—Salbutamol—ADRB2—coronary artery disease	0.000399	0.149	CrCbGaD
Salmeterol—Labetalol—ADRB1—coronary artery disease	0.000347	0.13	CrCbGaD
Salmeterol—Labetalol—ADRB2—coronary artery disease	0.000292	0.109	CrCbGaD
Salmeterol—Propafenone—ADRB1—coronary artery disease	0.000265	0.099	CrCbGaD
Salmeterol—Body temperature increased—Telmisartan—coronary artery disease	5.85e-05	0.000318	CcSEcCtD
Salmeterol—Dyspnoea—Losartan—coronary artery disease	5.84e-05	0.000317	CcSEcCtD
Salmeterol—Anxiety—Ramipril—coronary artery disease	5.84e-05	0.000317	CcSEcCtD
Salmeterol—Vomiting—Lovastatin—coronary artery disease	5.83e-05	0.000317	CcSEcCtD
Salmeterol—Dizziness—Eplerenone—coronary artery disease	5.82e-05	0.000316	CcSEcCtD
Salmeterol—Rash—Clopidogrel—coronary artery disease	5.82e-05	0.000316	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	5.82e-05	0.000316	CcSEcCtD
Salmeterol—Dermatitis—Clopidogrel—coronary artery disease	5.81e-05	0.000316	CcSEcCtD
Salmeterol—Asthenia—Valsartan—coronary artery disease	5.81e-05	0.000316	CcSEcCtD
Salmeterol—Hypertension—Timolol—coronary artery disease	5.81e-05	0.000316	CcSEcCtD
Salmeterol—Constipation—Furosemide—coronary artery disease	5.8e-05	0.000315	CcSEcCtD
Salmeterol—Pain—Furosemide—coronary artery disease	5.8e-05	0.000315	CcSEcCtD
Salmeterol—Hypersensitivity—Niacin—coronary artery disease	5.8e-05	0.000315	CcSEcCtD
Salmeterol—Ill-defined disorder—Lisinopril—coronary artery disease	5.79e-05	0.000315	CcSEcCtD
Salmeterol—Discomfort—Ramipril—coronary artery disease	5.79e-05	0.000315	CcSEcCtD
Salmeterol—Asthenia—Olmesartan—coronary artery disease	5.78e-05	0.000314	CcSEcCtD
Salmeterol—Headache—Clopidogrel—coronary artery disease	5.78e-05	0.000314	CcSEcCtD
Salmeterol—Rash—Lovastatin—coronary artery disease	5.78e-05	0.000314	CcSEcCtD
Salmeterol—Dermatitis—Lovastatin—coronary artery disease	5.78e-05	0.000314	CcSEcCtD
Salmeterol—Dyspepsia—Losartan—coronary artery disease	5.77e-05	0.000313	CcSEcCtD
Salmeterol—Feeling abnormal—Perindopril—coronary artery disease	5.75e-05	0.000313	CcSEcCtD
Salmeterol—Headache—Lovastatin—coronary artery disease	5.74e-05	0.000312	CcSEcCtD
Salmeterol—Dry mouth—Ramipril—coronary artery disease	5.73e-05	0.000311	CcSEcCtD
Salmeterol—Arthralgia—Timolol—coronary artery disease	5.73e-05	0.000311	CcSEcCtD
Salmeterol—Chest pain—Timolol—coronary artery disease	5.73e-05	0.000311	CcSEcCtD
Salmeterol—Myalgia—Timolol—coronary artery disease	5.73e-05	0.000311	CcSEcCtD
Salmeterol—Vomiting—Ezetimibe—coronary artery disease	5.72e-05	0.000311	CcSEcCtD
Salmeterol—Hypersensitivity—Pravastatin—coronary artery disease	5.71e-05	0.00031	CcSEcCtD
Salmeterol—Gastrointestinal pain—Perindopril—coronary artery disease	5.71e-05	0.00031	CcSEcCtD
Salmeterol—Anxiety—Timolol—coronary artery disease	5.71e-05	0.00031	CcSEcCtD
Salmeterol—Angioedema—Lisinopril—coronary artery disease	5.7e-05	0.00031	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.69e-05	0.000309	CcSEcCtD
Salmeterol—Body temperature increased—Captopril—coronary artery disease	5.69e-05	0.000309	CcSEcCtD
Salmeterol—Abdominal pain—Captopril—coronary artery disease	5.69e-05	0.000309	CcSEcCtD
Salmeterol—Dizziness—Simvastatin—coronary artery disease	5.67e-05	0.000308	CcSEcCtD
Salmeterol—Rash—Ezetimibe—coronary artery disease	5.67e-05	0.000308	CcSEcCtD
Salmeterol—Dermatitis—Ezetimibe—coronary artery disease	5.66e-05	0.000308	CcSEcCtD
Salmeterol—Discomfort—Timolol—coronary artery disease	5.66e-05	0.000307	CcSEcCtD
Salmeterol—Asthenia—Niacin—coronary artery disease	5.65e-05	0.000307	CcSEcCtD
Salmeterol—Fatigue—Losartan—coronary artery disease	5.65e-05	0.000307	CcSEcCtD
Salmeterol—Headache—Ezetimibe—coronary artery disease	5.63e-05	0.000306	CcSEcCtD
Salmeterol—Malaise—Lisinopril—coronary artery disease	5.63e-05	0.000306	CcSEcCtD
Salmeterol—Oedema—Ramipril—coronary artery disease	5.62e-05	0.000305	CcSEcCtD
Salmeterol—Anaphylactic shock—Ramipril—coronary artery disease	5.62e-05	0.000305	CcSEcCtD
Salmeterol—Dry mouth—Timolol—coronary artery disease	5.6e-05	0.000304	CcSEcCtD
Salmeterol—Pain—Losartan—coronary artery disease	5.6e-05	0.000304	CcSEcCtD
Salmeterol—Constipation—Losartan—coronary artery disease	5.6e-05	0.000304	CcSEcCtD
Salmeterol—Vomiting—Eplerenone—coronary artery disease	5.6e-05	0.000304	CcSEcCtD
Salmeterol—Feeling abnormal—Furosemide—coronary artery disease	5.59e-05	0.000304	CcSEcCtD
Salmeterol—Nausea—Fenofibrate—coronary artery disease	5.58e-05	0.000303	CcSEcCtD
Salmeterol—Asthenia—Pravastatin—coronary artery disease	5.56e-05	0.000302	CcSEcCtD
Salmeterol—Gastrointestinal pain—Furosemide—coronary artery disease	5.55e-05	0.000302	CcSEcCtD
Salmeterol—Rash—Eplerenone—coronary artery disease	5.55e-05	0.000302	CcSEcCtD
Salmeterol—Urticaria—Perindopril—coronary artery disease	5.55e-05	0.000301	CcSEcCtD
Salmeterol—Hypersensitivity—Trandolapril—coronary artery disease	5.55e-05	0.000301	CcSEcCtD
Salmeterol—Dermatitis—Eplerenone—coronary artery disease	5.54e-05	0.000301	CcSEcCtD
Salmeterol—Diarrhoea—Valsartan—coronary artery disease	5.54e-05	0.000301	CcSEcCtD
Salmeterol—Hypersensitivity—Enalapril—coronary artery disease	5.52e-05	0.0003	CcSEcCtD
Salmeterol—Abdominal pain—Perindopril—coronary artery disease	5.52e-05	0.0003	CcSEcCtD
Salmeterol—Body temperature increased—Perindopril—coronary artery disease	5.52e-05	0.0003	CcSEcCtD
Salmeterol—Palpitations—Lisinopril—coronary artery disease	5.52e-05	0.0003	CcSEcCtD
Salmeterol—Diarrhoea—Olmesartan—coronary artery disease	5.51e-05	0.0003	CcSEcCtD
Salmeterol—Headache—Eplerenone—coronary artery disease	5.51e-05	0.0003	CcSEcCtD
Salmeterol—Nervous system disorder—Ramipril—coronary artery disease	5.51e-05	0.000299	CcSEcCtD
Salmeterol—Oedema—Timolol—coronary artery disease	5.49e-05	0.000298	CcSEcCtD
Salmeterol—Anaphylactic shock—Timolol—coronary artery disease	5.49e-05	0.000298	CcSEcCtD
Salmeterol—Nausea—Clopidogrel—coronary artery disease	5.48e-05	0.000298	CcSEcCtD
Salmeterol—Tachycardia—Ramipril—coronary artery disease	5.48e-05	0.000298	CcSEcCtD
Salmeterol—Skin disorder—Ramipril—coronary artery disease	5.46e-05	0.000296	CcSEcCtD
Salmeterol—Infection—Timolol—coronary artery disease	5.45e-05	0.000296	CcSEcCtD
Salmeterol—Vomiting—Simvastatin—coronary artery disease	5.45e-05	0.000296	CcSEcCtD
Salmeterol—Hypersensitivity—Telmisartan—coronary artery disease	5.45e-05	0.000296	CcSEcCtD
Salmeterol—Cough—Lisinopril—coronary artery disease	5.45e-05	0.000296	CcSEcCtD
Salmeterol—Nausea—Lovastatin—coronary artery disease	5.45e-05	0.000296	CcSEcCtD
Salmeterol—Rash—Simvastatin—coronary artery disease	5.41e-05	0.000294	CcSEcCtD
Salmeterol—Dermatitis—Simvastatin—coronary artery disease	5.4e-05	0.000294	CcSEcCtD
Salmeterol—Asthenia—Trandolapril—coronary artery disease	5.4e-05	0.000294	CcSEcCtD
Salmeterol—Feeling abnormal—Losartan—coronary artery disease	5.4e-05	0.000293	CcSEcCtD
Salmeterol—Urticaria—Furosemide—coronary artery disease	5.39e-05	0.000293	CcSEcCtD
Salmeterol—Diarrhoea—Niacin—coronary artery disease	5.39e-05	0.000293	CcSEcCtD
Salmeterol—Nervous system disorder—Timolol—coronary artery disease	5.38e-05	0.000293	CcSEcCtD
Salmeterol—Asthenia—Enalapril—coronary artery disease	5.38e-05	0.000292	CcSEcCtD
Salmeterol—Headache—Simvastatin—coronary artery disease	5.37e-05	0.000292	CcSEcCtD
Salmeterol—Body temperature increased—Furosemide—coronary artery disease	5.37e-05	0.000292	CcSEcCtD
Salmeterol—Abdominal pain—Furosemide—coronary artery disease	5.37e-05	0.000292	CcSEcCtD
Salmeterol—Gastrointestinal pain—Losartan—coronary artery disease	5.36e-05	0.000291	CcSEcCtD
Salmeterol—Dizziness—Valsartan—coronary artery disease	5.36e-05	0.000291	CcSEcCtD
Salmeterol—Nausea—Ezetimibe—coronary artery disease	5.34e-05	0.00029	CcSEcCtD
Salmeterol—Skin disorder—Timolol—coronary artery disease	5.33e-05	0.00029	CcSEcCtD
Salmeterol—Dizziness—Olmesartan—coronary artery disease	5.33e-05	0.00029	CcSEcCtD
Salmeterol—Arthralgia—Lisinopril—coronary artery disease	5.31e-05	0.000289	CcSEcCtD
Salmeterol—Chest pain—Lisinopril—coronary artery disease	5.31e-05	0.000289	CcSEcCtD
Salmeterol—Myalgia—Lisinopril—coronary artery disease	5.31e-05	0.000289	CcSEcCtD
Salmeterol—Asthenia—Telmisartan—coronary artery disease	5.31e-05	0.000288	CcSEcCtD
Salmeterol—Diarrhoea—Pravastatin—coronary artery disease	5.3e-05	0.000288	CcSEcCtD
Salmeterol—Anxiety—Lisinopril—coronary artery disease	5.29e-05	0.000288	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.28e-05	0.000287	CcSEcCtD
Salmeterol—Discomfort—Lisinopril—coronary artery disease	5.25e-05	0.000285	CcSEcCtD
Salmeterol—Nausea—Eplerenone—coronary artery disease	5.23e-05	0.000284	CcSEcCtD
Salmeterol—Dizziness—Niacin—coronary artery disease	5.21e-05	0.000283	CcSEcCtD
Salmeterol—Urticaria—Losartan—coronary artery disease	5.2e-05	0.000283	CcSEcCtD
Salmeterol—Dry mouth—Lisinopril—coronary artery disease	5.2e-05	0.000282	CcSEcCtD
Salmeterol—Abdominal pain—Losartan—coronary artery disease	5.18e-05	0.000281	CcSEcCtD
Salmeterol—Body temperature increased—Losartan—coronary artery disease	5.18e-05	0.000281	CcSEcCtD
Salmeterol—Asthenia—Captopril—coronary artery disease	5.16e-05	0.00028	CcSEcCtD
Salmeterol—Diarrhoea—Trandolapril—coronary artery disease	5.15e-05	0.00028	CcSEcCtD
Salmeterol—Vomiting—Valsartan—coronary artery disease	5.15e-05	0.00028	CcSEcCtD
Salmeterol—Diarrhoea—Enalapril—coronary artery disease	5.13e-05	0.000279	CcSEcCtD
Salmeterol—Dizziness—Pravastatin—coronary artery disease	5.13e-05	0.000279	CcSEcCtD
Salmeterol—Vomiting—Olmesartan—coronary artery disease	5.12e-05	0.000278	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.12e-05	0.000278	CcSEcCtD
Salmeterol—Rash—Valsartan—coronary artery disease	5.11e-05	0.000277	CcSEcCtD
Salmeterol—Dermatitis—Valsartan—coronary artery disease	5.1e-05	0.000277	CcSEcCtD
Salmeterol—Nausea—Simvastatin—coronary artery disease	5.09e-05	0.000277	CcSEcCtD
Salmeterol—Oedema—Lisinopril—coronary artery disease	5.09e-05	0.000277	CcSEcCtD
Salmeterol—Anaphylactic shock—Lisinopril—coronary artery disease	5.09e-05	0.000277	CcSEcCtD
Salmeterol—Rash—Olmesartan—coronary artery disease	5.08e-05	0.000276	CcSEcCtD
Salmeterol—Insomnia—Ramipril—coronary artery disease	5.08e-05	0.000276	CcSEcCtD
Salmeterol—Dermatitis—Olmesartan—coronary artery disease	5.08e-05	0.000276	CcSEcCtD
Salmeterol—Headache—Valsartan—coronary artery disease	5.07e-05	0.000276	CcSEcCtD
Salmeterol—Diarrhoea—Telmisartan—coronary artery disease	5.06e-05	0.000275	CcSEcCtD
Salmeterol—Infection—Lisinopril—coronary artery disease	5.06e-05	0.000275	CcSEcCtD
Salmeterol—Headache—Olmesartan—coronary artery disease	5.05e-05	0.000274	CcSEcCtD
Salmeterol—Paraesthesia—Ramipril—coronary artery disease	5.04e-05	0.000274	CcSEcCtD
Salmeterol—Asthenia—Perindopril—coronary artery disease	5.01e-05	0.000272	CcSEcCtD
Salmeterol—Dyspnoea—Ramipril—coronary artery disease	5.01e-05	0.000272	CcSEcCtD
Salmeterol—Vomiting—Niacin—coronary artery disease	5.01e-05	0.000272	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Timolol—coronary artery disease	5e-05	0.000272	CcSEcCtD
Salmeterol—Hypersensitivity—Furosemide—coronary artery disease	5e-05	0.000272	CcSEcCtD
Salmeterol—Dizziness—Trandolapril—coronary artery disease	4.98e-05	0.000271	CcSEcCtD
Salmeterol—Tachycardia—Lisinopril—coronary artery disease	4.97e-05	0.00027	CcSEcCtD
Salmeterol—Insomnia—Timolol—coronary artery disease	4.97e-05	0.00027	CcSEcCtD
Salmeterol—Rash—Niacin—coronary artery disease	4.96e-05	0.00027	CcSEcCtD
Salmeterol—Dermatitis—Niacin—coronary artery disease	4.96e-05	0.00027	CcSEcCtD
Salmeterol—Dizziness—Enalapril—coronary artery disease	4.96e-05	0.000269	CcSEcCtD
Salmeterol—Skin disorder—Lisinopril—coronary artery disease	4.95e-05	0.000269	CcSEcCtD
Salmeterol—Dyspepsia—Ramipril—coronary artery disease	4.94e-05	0.000269	CcSEcCtD
Salmeterol—Headache—Niacin—coronary artery disease	4.93e-05	0.000268	CcSEcCtD
Salmeterol—Paraesthesia—Timolol—coronary artery disease	4.93e-05	0.000268	CcSEcCtD
Salmeterol—Vomiting—Pravastatin—coronary artery disease	4.93e-05	0.000268	CcSEcCtD
Salmeterol—Diarrhoea—Captopril—coronary artery disease	4.92e-05	0.000267	CcSEcCtD
Salmeterol—Dyspnoea—Timolol—coronary artery disease	4.89e-05	0.000266	CcSEcCtD
Salmeterol—Dizziness—Telmisartan—coronary artery disease	4.89e-05	0.000266	CcSEcCtD
Salmeterol—Rash—Pravastatin—coronary artery disease	4.89e-05	0.000266	CcSEcCtD
Salmeterol—Dermatitis—Pravastatin—coronary artery disease	4.88e-05	0.000265	CcSEcCtD
Salmeterol—Asthenia—Furosemide—coronary artery disease	4.87e-05	0.000265	CcSEcCtD
Salmeterol—Headache—Pravastatin—coronary artery disease	4.86e-05	0.000264	CcSEcCtD
Salmeterol—Fatigue—Ramipril—coronary artery disease	4.84e-05	0.000263	CcSEcCtD
Salmeterol—Dyspepsia—Timolol—coronary artery disease	4.83e-05	0.000263	CcSEcCtD
Salmeterol—Hypersensitivity—Losartan—coronary artery disease	4.83e-05	0.000262	CcSEcCtD
Salmeterol—Nausea—Valsartan—coronary artery disease	4.81e-05	0.000261	CcSEcCtD
Salmeterol—Constipation—Ramipril—coronary artery disease	4.8e-05	0.000261	CcSEcCtD
Salmeterol—Nausea—Olmesartan—coronary artery disease	4.79e-05	0.00026	CcSEcCtD
Salmeterol—Vomiting—Trandolapril—coronary artery disease	4.79e-05	0.00026	CcSEcCtD
Salmeterol—Diarrhoea—Perindopril—coronary artery disease	4.78e-05	0.00026	CcSEcCtD
Salmeterol—Vomiting—Enalapril—coronary artery disease	4.77e-05	0.000259	CcSEcCtD
Salmeterol—Dizziness—Captopril—coronary artery disease	4.76e-05	0.000258	CcSEcCtD
Salmeterol—Rash—Trandolapril—coronary artery disease	4.75e-05	0.000258	CcSEcCtD
Salmeterol—Dermatitis—Trandolapril—coronary artery disease	4.74e-05	0.000258	CcSEcCtD
Salmeterol—Fatigue—Timolol—coronary artery disease	4.73e-05	0.000257	CcSEcCtD
Salmeterol—Rash—Enalapril—coronary artery disease	4.73e-05	0.000257	CcSEcCtD
Salmeterol—Dermatitis—Enalapril—coronary artery disease	4.72e-05	0.000257	CcSEcCtD
Salmeterol—Headache—Trandolapril—coronary artery disease	4.72e-05	0.000256	CcSEcCtD
Salmeterol—Vomiting—Telmisartan—coronary artery disease	4.7e-05	0.000256	CcSEcCtD
Salmeterol—Asthenia—Losartan—coronary artery disease	4.7e-05	0.000255	CcSEcCtD
Salmeterol—Headache—Enalapril—coronary artery disease	4.7e-05	0.000255	CcSEcCtD
Salmeterol—Pain—Timolol—coronary artery disease	4.7e-05	0.000255	CcSEcCtD
Salmeterol—Nausea—Niacin—coronary artery disease	4.68e-05	0.000254	CcSEcCtD
Salmeterol—Rash—Telmisartan—coronary artery disease	4.66e-05	0.000253	CcSEcCtD
Salmeterol—Dermatitis—Telmisartan—coronary artery disease	4.66e-05	0.000253	CcSEcCtD
Salmeterol—Diarrhoea—Furosemide—coronary artery disease	4.64e-05	0.000252	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.64e-05	0.000252	CcSEcCtD
Salmeterol—Headache—Telmisartan—coronary artery disease	4.63e-05	0.000252	CcSEcCtD
Salmeterol—Feeling abnormal—Ramipril—coronary artery disease	4.63e-05	0.000251	CcSEcCtD
Salmeterol—Dizziness—Perindopril—coronary artery disease	4.62e-05	0.000251	CcSEcCtD
Salmeterol—Insomnia—Lisinopril—coronary artery disease	4.61e-05	0.00025	CcSEcCtD
Salmeterol—Nausea—Pravastatin—coronary artery disease	4.61e-05	0.00025	CcSEcCtD
Salmeterol—Gastrointestinal pain—Ramipril—coronary artery disease	4.59e-05	0.00025	CcSEcCtD
Salmeterol—Paraesthesia—Lisinopril—coronary artery disease	4.57e-05	0.000249	CcSEcCtD
Salmeterol—Vomiting—Captopril—coronary artery disease	4.57e-05	0.000248	CcSEcCtD
Salmeterol—Dyspnoea—Lisinopril—coronary artery disease	4.54e-05	0.000247	CcSEcCtD
Salmeterol—Rash—Captopril—coronary artery disease	4.53e-05	0.000246	CcSEcCtD
Salmeterol—Dermatitis—Captopril—coronary artery disease	4.53e-05	0.000246	CcSEcCtD
Salmeterol—Feeling abnormal—Timolol—coronary artery disease	4.52e-05	0.000246	CcSEcCtD
Salmeterol—Headache—Captopril—coronary artery disease	4.51e-05	0.000245	CcSEcCtD
Salmeterol—Gastrointestinal pain—Timolol—coronary artery disease	4.49e-05	0.000244	CcSEcCtD
Salmeterol—Dizziness—Furosemide—coronary artery disease	4.49e-05	0.000244	CcSEcCtD
Salmeterol—Dyspepsia—Lisinopril—coronary artery disease	4.48e-05	0.000244	CcSEcCtD
Salmeterol—Diarrhoea—Losartan—coronary artery disease	4.48e-05	0.000244	CcSEcCtD
Salmeterol—Nausea—Trandolapril—coronary artery disease	4.47e-05	0.000243	CcSEcCtD
Salmeterol—Urticaria—Ramipril—coronary artery disease	4.46e-05	0.000242	CcSEcCtD
Salmeterol—Nausea—Enalapril—coronary artery disease	4.45e-05	0.000242	CcSEcCtD
Salmeterol—Vomiting—Perindopril—coronary artery disease	4.44e-05	0.000241	CcSEcCtD
Salmeterol—Abdominal pain—Ramipril—coronary artery disease	4.44e-05	0.000241	CcSEcCtD
Salmeterol—Body temperature increased—Ramipril—coronary artery disease	4.44e-05	0.000241	CcSEcCtD
Salmeterol—Rash—Perindopril—coronary artery disease	4.4e-05	0.000239	CcSEcCtD
Salmeterol—Dermatitis—Perindopril—coronary artery disease	4.4e-05	0.000239	CcSEcCtD
Salmeterol—Nausea—Telmisartan—coronary artery disease	4.39e-05	0.000239	CcSEcCtD
Salmeterol—Fatigue—Lisinopril—coronary artery disease	4.39e-05	0.000239	CcSEcCtD
Salmeterol—Headache—Perindopril—coronary artery disease	4.37e-05	0.000238	CcSEcCtD
Salmeterol—Urticaria—Timolol—coronary artery disease	4.36e-05	0.000237	CcSEcCtD
Salmeterol—Constipation—Lisinopril—coronary artery disease	4.36e-05	0.000237	CcSEcCtD
Salmeterol—Pain—Lisinopril—coronary artery disease	4.36e-05	0.000237	CcSEcCtD
Salmeterol—Body temperature increased—Timolol—coronary artery disease	4.34e-05	0.000236	CcSEcCtD
Salmeterol—Abdominal pain—Timolol—coronary artery disease	4.34e-05	0.000236	CcSEcCtD
Salmeterol—Dizziness—Losartan—coronary artery disease	4.33e-05	0.000235	CcSEcCtD
Salmeterol—Vomiting—Furosemide—coronary artery disease	4.32e-05	0.000235	CcSEcCtD
Salmeterol—Rash—Furosemide—coronary artery disease	4.28e-05	0.000233	CcSEcCtD
Salmeterol—Dermatitis—Furosemide—coronary artery disease	4.28e-05	0.000232	CcSEcCtD
Salmeterol—Nausea—Captopril—coronary artery disease	4.27e-05	0.000232	CcSEcCtD
Salmeterol—Headache—Furosemide—coronary artery disease	4.25e-05	0.000231	CcSEcCtD
Salmeterol—Feeling abnormal—Lisinopril—coronary artery disease	4.2e-05	0.000228	CcSEcCtD
Salmeterol—Gastrointestinal pain—Lisinopril—coronary artery disease	4.16e-05	0.000226	CcSEcCtD
Salmeterol—Vomiting—Losartan—coronary artery disease	4.16e-05	0.000226	CcSEcCtD
Salmeterol—Nausea—Perindopril—coronary artery disease	4.15e-05	0.000225	CcSEcCtD
Salmeterol—Hypersensitivity—Ramipril—coronary artery disease	4.14e-05	0.000225	CcSEcCtD
Salmeterol—Rash—Losartan—coronary artery disease	4.13e-05	0.000224	CcSEcCtD
Salmeterol—Dermatitis—Losartan—coronary artery disease	4.13e-05	0.000224	CcSEcCtD
Salmeterol—Headache—Losartan—coronary artery disease	4.1e-05	0.000223	CcSEcCtD
Salmeterol—Urticaria—Lisinopril—coronary artery disease	4.05e-05	0.00022	CcSEcCtD
Salmeterol—Hypersensitivity—Timolol—coronary artery disease	4.05e-05	0.00022	CcSEcCtD
Salmeterol—Nausea—Furosemide—coronary artery disease	4.03e-05	0.000219	CcSEcCtD
Salmeterol—Asthenia—Ramipril—coronary artery disease	4.03e-05	0.000219	CcSEcCtD
Salmeterol—Body temperature increased—Lisinopril—coronary artery disease	4.03e-05	0.000219	CcSEcCtD
Salmeterol—Abdominal pain—Lisinopril—coronary artery disease	4.03e-05	0.000219	CcSEcCtD
Salmeterol—Asthenia—Timolol—coronary artery disease	3.94e-05	0.000214	CcSEcCtD
Salmeterol—Nausea—Losartan—coronary artery disease	3.89e-05	0.000211	CcSEcCtD
Salmeterol—Diarrhoea—Ramipril—coronary artery disease	3.84e-05	0.000209	CcSEcCtD
Salmeterol—Diarrhoea—Timolol—coronary artery disease	3.76e-05	0.000204	CcSEcCtD
Salmeterol—Hypersensitivity—Lisinopril—coronary artery disease	3.75e-05	0.000204	CcSEcCtD
Salmeterol—Dizziness—Ramipril—coronary artery disease	3.71e-05	0.000202	CcSEcCtD
Salmeterol—Asthenia—Lisinopril—coronary artery disease	3.65e-05	0.000199	CcSEcCtD
Salmeterol—Dizziness—Timolol—coronary artery disease	3.63e-05	0.000197	CcSEcCtD
Salmeterol—Vomiting—Ramipril—coronary artery disease	3.57e-05	0.000194	CcSEcCtD
Salmeterol—Rash—Ramipril—coronary artery disease	3.54e-05	0.000192	CcSEcCtD
Salmeterol—Dermatitis—Ramipril—coronary artery disease	3.54e-05	0.000192	CcSEcCtD
Salmeterol—Headache—Ramipril—coronary artery disease	3.52e-05	0.000191	CcSEcCtD
Salmeterol—Vomiting—Timolol—coronary artery disease	3.49e-05	0.00019	CcSEcCtD
Salmeterol—Diarrhoea—Lisinopril—coronary artery disease	3.48e-05	0.000189	CcSEcCtD
Salmeterol—Rash—Timolol—coronary artery disease	3.46e-05	0.000188	CcSEcCtD
Salmeterol—Dermatitis—Timolol—coronary artery disease	3.46e-05	0.000188	CcSEcCtD
Salmeterol—Headache—Timolol—coronary artery disease	3.44e-05	0.000187	CcSEcCtD
Salmeterol—Dizziness—Lisinopril—coronary artery disease	3.37e-05	0.000183	CcSEcCtD
Salmeterol—Nausea—Ramipril—coronary artery disease	3.34e-05	0.000181	CcSEcCtD
Salmeterol—Nausea—Timolol—coronary artery disease	3.26e-05	0.000177	CcSEcCtD
Salmeterol—Vomiting—Lisinopril—coronary artery disease	3.24e-05	0.000176	CcSEcCtD
Salmeterol—Rash—Lisinopril—coronary artery disease	3.21e-05	0.000175	CcSEcCtD
Salmeterol—Dermatitis—Lisinopril—coronary artery disease	3.21e-05	0.000174	CcSEcCtD
Salmeterol—Headache—Lisinopril—coronary artery disease	3.19e-05	0.000173	CcSEcCtD
Salmeterol—Nausea—Lisinopril—coronary artery disease	3.03e-05	0.000164	CcSEcCtD
Salmeterol—CYP3A7—Metabolism—HMOX1—coronary artery disease	6.81e-06	0.000192	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DCN—coronary artery disease	6.74e-06	0.00019	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CAT—coronary artery disease	6.72e-06	0.00019	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PYGB—coronary artery disease	6.7e-06	0.000189	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CKB—coronary artery disease	6.7e-06	0.000189	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PSMA6—coronary artery disease	6.65e-06	0.000188	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PSMB5—coronary artery disease	6.65e-06	0.000188	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALDH2—coronary artery disease	6.56e-06	0.000185	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	6.56e-06	0.000185	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	6.54e-06	0.000185	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOB—coronary artery disease	6.52e-06	0.000184	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	6.52e-06	0.000184	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	6.52e-06	0.000184	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	6.5e-06	0.000183	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CTGF—coronary artery disease	6.5e-06	0.000183	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HMGCR—coronary artery disease	6.44e-06	0.000182	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GOT2—coronary artery disease	6.44e-06	0.000182	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.39e-06	0.00018	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	6.39e-06	0.00018	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2C19—coronary artery disease	6.39e-06	0.00018	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HBA1—coronary artery disease	6.39e-06	0.00018	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LIPC—coronary artery disease	6.39e-06	0.00018	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	6.38e-06	0.00018	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	6.36e-06	0.000179	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOC3—coronary artery disease	6.35e-06	0.000179	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	6.35e-06	0.000179	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTM1—coronary artery disease	6.35e-06	0.000179	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PLG—coronary artery disease	6.33e-06	0.000179	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LDLR—coronary artery disease	6.31e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.31e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PFKFB3—coronary artery disease	6.3e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLIN1—coronary artery disease	6.3e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DLAT—coronary artery disease	6.3e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—COX5B—coronary artery disease	6.3e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTM2—coronary artery disease	6.3e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC9A1—coronary artery disease	6.24e-06	0.000176	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTT1—coronary artery disease	6.24e-06	0.000176	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LPL—coronary artery disease	6.23e-06	0.000176	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GCLC—coronary artery disease	6.17e-06	0.000174	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CETP—coronary artery disease	6.17e-06	0.000174	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SDC1—coronary artery disease	6.1e-06	0.000172	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	6.09e-06	0.000172	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	6.08e-06	0.000172	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GPX1—coronary artery disease	6.08e-06	0.000172	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	6.07e-06	0.000171	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—S100B—coronary artery disease	6.06e-06	0.000171	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	6e-06	0.000169	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.97e-06	0.000169	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	5.93e-06	0.000167	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	5.93e-06	0.000167	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLCB1—coronary artery disease	5.92e-06	0.000167	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CD36—coronary artery disease	5.92e-06	0.000167	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPP2CA—coronary artery disease	5.84e-06	0.000165	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	5.79e-06	0.000163	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	5.79e-06	0.000163	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PSMB5—coronary artery disease	5.76e-06	0.000163	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PSMA6—coronary artery disease	5.76e-06	0.000163	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.75e-06	0.000162	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCA1—coronary artery disease	5.74e-06	0.000162	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.7e-06	0.000161	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HK2—coronary artery disease	5.7e-06	0.000161	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CTGF—coronary artery disease	5.63e-06	0.000159	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MTHFR—coronary artery disease	5.61e-06	0.000158	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOB—coronary artery disease	5.6e-06	0.000158	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HMGCR—coronary artery disease	5.58e-06	0.000157	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT2—coronary artery disease	5.58e-06	0.000157	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GGT1—coronary artery disease	5.56e-06	0.000157	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GOT1—coronary artery disease	5.56e-06	0.000157	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	5.55e-06	0.000157	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	5.52e-06	0.000156	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	5.51e-06	0.000155	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	5.47e-06	0.000154	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.46e-06	0.000154	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	5.39e-06	0.000152	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	5.39e-06	0.000152	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LCAT—coronary artery disease	5.36e-06	0.000151	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.36e-06	0.000151	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LPL—coronary artery disease	5.35e-06	0.000151	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AGT—coronary artery disease	5.33e-06	0.00015	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	5.3e-06	0.00015	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	5.3e-06	0.00015	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA4—coronary artery disease	5.26e-06	0.000148	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOE—coronary artery disease	5.22e-06	0.000147	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	5.16e-06	0.000146	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOA1—coronary artery disease	5.16e-06	0.000146	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLCB1—coronary artery disease	5.13e-06	0.000145	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCLM—coronary artery disease	5.08e-06	0.000143	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PDHA1—coronary artery disease	5.08e-06	0.000143	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	5.04e-06	0.000142	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.03e-06	0.000142	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	5.02e-06	0.000142	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTP1—coronary artery disease	4.99e-06	0.000141	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCA1—coronary artery disease	4.97e-06	0.00014	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	4.95e-06	0.00014	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	4.93e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HMOX1—coronary artery disease	4.92e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.92e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.92e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CAT—coronary artery disease	4.86e-06	0.000137	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.84e-06	0.000137	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	4.82e-06	0.000136	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT1—coronary artery disease	4.81e-06	0.000136	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GGT1—coronary artery disease	4.81e-06	0.000136	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—C3—coronary artery disease	4.81e-06	0.000136	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.77e-06	0.000135	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HADH—coronary artery disease	4.77e-06	0.000135	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOB—coronary artery disease	4.72e-06	0.000133	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	4.59e-06	0.00013	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTM1—coronary artery disease	4.59e-06	0.000129	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AGT—coronary artery disease	4.57e-06	0.000129	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARG—coronary artery disease	4.55e-06	0.000128	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GPX2—coronary artery disease	4.53e-06	0.000128	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA2—coronary artery disease	4.53e-06	0.000128	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.53e-06	0.000128	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPL—coronary artery disease	4.5e-06	0.000127	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—POMC—coronary artery disease	4.49e-06	0.000127	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LEP—coronary artery disease	4.48e-06	0.000126	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOE—coronary artery disease	4.48e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GPX4—coronary artery disease	4.47e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.47e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.47e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HK1—coronary artery disease	4.47e-06	0.000126	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	4.43e-06	0.000125	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HADHA—coronary artery disease	4.42e-06	0.000125	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GPX1—coronary artery disease	4.39e-06	0.000124	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KDR—coronary artery disease	4.39e-06	0.000124	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.37e-06	0.000123	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	4.36e-06	0.000123	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTP1—coronary artery disease	4.32e-06	0.000122	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPA—coronary artery disease	4.32e-06	0.000122	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	4.28e-06	0.000121	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	4.28e-06	0.000121	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CD36—coronary artery disease	4.28e-06	0.000121	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HMOX1—coronary artery disease	4.26e-06	0.00012	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—F2—coronary artery disease	4.23e-06	0.000119	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FN1—coronary artery disease	4.23e-06	0.000119	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPP2CA—coronary artery disease	4.22e-06	0.000119	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	4.21e-06	0.000119	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CAT—coronary artery disease	4.21e-06	0.000119	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.18e-06	0.000118	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	4.18e-06	0.000118	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA5—coronary artery disease	4.14e-06	0.000117	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALB—coronary artery disease	4.09e-06	0.000115	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOB—coronary artery disease	4.08e-06	0.000115	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—P4HB—coronary artery disease	4.06e-06	0.000115	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MTHFR—coronary artery disease	4.05e-06	0.000114	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KIT—coronary artery disease	4.04e-06	0.000114	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.99e-06	0.000112	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.97e-06	0.000112	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NOS3—coronary artery disease	3.91e-06	0.00011	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPL—coronary artery disease	3.9e-06	0.00011	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	3.88e-06	0.00011	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AGT—coronary artery disease	3.85e-06	0.000109	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	3.85e-06	0.000109	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—POMC—coronary artery disease	3.85e-06	0.000109	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GPX1—coronary artery disease	3.81e-06	0.000107	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOE—coronary artery disease	3.77e-06	0.000107	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	3.77e-06	0.000106	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—VCAN—coronary artery disease	3.76e-06	0.000106	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	3.76e-06	0.000106	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOA1—coronary artery disease	3.73e-06	0.000105	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.73e-06	0.000105	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CD36—coronary artery disease	3.71e-06	0.000105	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	3.7e-06	0.000104	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	3.69e-06	0.000104	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPP2CA—coronary artery disease	3.66e-06	0.000103	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DCN—coronary artery disease	3.62e-06	0.000102	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—coronary artery disease	3.58e-06	0.000101	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	3.52e-06	9.94e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.52e-06	9.93e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	3.52e-06	9.92e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MTHFR—coronary artery disease	3.51e-06	9.91e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.43e-06	9.68e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LIPC—coronary artery disease	3.43e-06	9.68e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HBA1—coronary artery disease	3.43e-06	9.68e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.43e-06	9.68e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOC3—coronary artery disease	3.41e-06	9.62e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	3.4e-06	9.61e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LDLR—coronary artery disease	3.39e-06	9.56e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	3.36e-06	9.47e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.35e-06	9.45e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.35e-06	9.45e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AGT—coronary artery disease	3.34e-06	9.42e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCLC—coronary artery disease	3.31e-06	9.34e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CETP—coronary artery disease	3.31e-06	9.34e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARG—coronary artery disease	3.29e-06	9.28e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SDC1—coronary artery disease	3.27e-06	9.24e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOE—coronary artery disease	3.27e-06	9.23e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	3.26e-06	9.21e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—POMC—coronary artery disease	3.24e-06	9.15e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOA1—coronary artery disease	3.23e-06	9.12e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	3.2e-06	9.02e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.09e-06	8.73e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.09e-06	8.72e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.09e-06	8.72e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CTGF—coronary artery disease	3.02e-06	8.52e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.99e-06	8.45e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT2—coronary artery disease	2.99e-06	8.45e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	2.98e-06	8.4e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALB—coronary artery disease	2.96e-06	8.34e-05	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	2.88e-06	8.12e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	2.85e-06	8.04e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARG—coronary artery disease	2.85e-06	8.04e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	2.83e-06	7.99e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NOS3—coronary artery disease	2.83e-06	7.98e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—POMC—coronary artery disease	2.81e-06	7.93e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	2.77e-06	7.83e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.75e-06	7.77e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	2.69e-06	7.6e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.67e-06	7.53e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	2.61e-06	7.37e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.59e-06	7.3e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GGT1—coronary artery disease	2.58e-06	7.29e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT1—coronary artery disease	2.58e-06	7.29e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALB—coronary artery disease	2.56e-06	7.23e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NOS3—coronary artery disease	2.45e-06	6.91e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	2.42e-06	6.83e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.32e-06	6.55e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.3e-06	6.49e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.29e-06	6.46e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CAT—coronary artery disease	2.26e-06	6.37e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—coronary artery disease	2.24e-06	6.32e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	2.22e-06	6.26e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3CA—coronary artery disease	2.2e-06	6.21e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOB—coronary artery disease	2.19e-06	6.19e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	2.18e-06	6.14e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.13e-06	6.02e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPL—coronary artery disease	2.09e-06	5.91e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GPX1—coronary artery disease	2.04e-06	5.76e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CD36—coronary artery disease	1.99e-06	5.61e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.96e-06	5.54e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.89e-06	5.33e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.88e-06	5.32e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AKT1—coronary artery disease	1.8e-06	5.07e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AGT—coronary artery disease	1.79e-06	5.05e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOE—coronary artery disease	1.75e-06	4.95e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA1—coronary artery disease	1.73e-06	4.9e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—coronary artery disease	1.67e-06	4.72e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.59e-06	4.49e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.54e-06	4.36e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARG—coronary artery disease	1.53e-06	4.31e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—POMC—coronary artery disease	1.51e-06	4.25e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.38e-06	3.89e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALB—coronary artery disease	1.37e-06	3.88e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NOS3—coronary artery disease	1.31e-06	3.71e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AKT1—coronary artery disease	1.3e-06	3.67e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.2e-06	3.39e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AKT1—coronary artery disease	1.13e-06	3.18e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.4e-07	2.09e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AKT1—coronary artery disease	6.04e-07	1.71e-05	CbGpPWpGaD
